Total Funding
44
52
Total FundingFunding Round raised
Growth Score
-1 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
80061
4P-Pharma is a clinical-stage company that develops regenerating active drugs and therapies to cure untreated serious diseases.
- Jérôme Vailland: Administrative & Chief Financial OfficerPast Role: Coave Therapeutics, Chief Financial Officer
About the Company
4P-Pharma is a clinical-stage company developing regenerative active drugs and therapies to cure previously untreatable serious diseases. The company applies artificial intelligence and biological data analysis to design molecules and prioritize targets across multiple disease areas. Its platform integrates omics data, disease modeling, and
cheminformatics to support early-stage drug development decisions. 4P-Pharma collaborates with research organizations and industry partners to advance selected programs toward preclinical validation. The company focuses on generating and licensing drug candidates while supporting partners with research insights and development strategies.
